AMSA Pharm-free Scorecard 2010
B Drexel University College of Medicine
City: Philadelphia State: PA

Summary: Overall, the Drexel University College of Medicine policy is strong in the following domains: purchasing & formularies, off-site education, scholarships and trainee funds, curriculum, and oversight & sanctions. Yet, the policy could be improved by banning all gifts, regardless of value and mandating an institutional review, or approval of all consulting relationships. Although prior written approval for participation in speaker's bureaus is required, participation in speaker's bureaus is not prohibited. Public disclosure of financial conflicts of interest is not required and disclosure is limited to financial interests greater than $10,000 and consulting relationships (including speaking relationships) greater than $300. Samples are accessible to all department members and only restricted to being logged-in and logged-out. This does not limit the use of samples as a marketing tool. Furthermore, designating a central fund for non-Continuing Medical Education activities is needed in place of designating at the department level. 

Demographics: On average students spend 33% of their training at Hahnemann University Hospital, 33% at St. Christopher's Hospital for Children, and 12% at Allegheny General Hospital . Students are instructed to follow submitted policies on and off the home campus unless the host/affiliate institution has a more strict policy however it is unclear how the policies apply to faculty and clinical educators at various sites.

UpdatesThis institution did not submit any new or additional policies for the 2012-13 AMSA PharmFree Scorecard. This institution's evaluation was last updated: 01/01/2012

This institution has not indicated consent to allow the public posting of their policies.    

Gifts & Meals 2 Gifts of value less than $25 are not prohibited in the policy.
Consulting relationships 2 Consulting relationships do not require institutional review or approval, but must be detailed in a contract, showcasing compensation that is fair market value.
Industry-funded speaking relationships 2 Participation in speaker's bureaus are not prohibited but prior written approval of participation in speaker's bureaus is required. Additional speaking relationships are permitted and requires the speaker to have control of the presentation and to annually disclose financial interests of more than $300.
Disclosure 1 The policy does not mandate public disclosure of all financial ties between personnel and the pharmaceutical industry. Disclosure is limited to consulting relationships, including speaking relationships of more than $300, in addition to financial interests of more than $10,000.
Pharmaceutical samples 1 The policy makes samples available for distribution to all department members and only restricts samples to be logged-in and logged-out.
Purchasing & Formularies 3 Members are required to disclose their financial conflicts of interests prior to the selection process, and, if necessary, must recuse themselves.
Industry Sales Representatives 2 Industry sales representatives can only meet with faculty by appointment.
On-campus Education 2 The UCoM office of CME or an outside accredited Office of CME serves as the central fund for CME activities.  Non-CME activities are designated at the department level, in which oversight is provided by the Department Chair.
Attendance at Industry-Sponsored Lectures & Meetings Off-Campus 3 The policy prohibits payment for attendance at off-site lectures and meetings.  Additional payments used for travel to off-site lectures and meetings are require advanced approval by the Department Chair.
Industry Support for Scholarships & Funds for Trainees 3 Funds for scholarships/trainee funds can be accepted from the industry provided that department faculty choose the recipient of the funds.
Medical school curriculum 3 Submitted a curriculum that details pharmaceutical marketing, conflicts of interest and how to avoid conflicts of interests.
Do the policies specify an oversight mechanism? Yes It is clear that the UCoM Dean or the designee assigned by the Dean is responsible for general oversight to ensure compliance.
Are there explicit sanctions for noncompliance? Yes Sanctions for noncompliance are clearly stated in the policy.
What the results mean...
3Model policy
2Good progress toward model policy
1No policy, or policy unlikely to have a substantial effect on behavior
0Did not report
N/APolicy not relevant to this institution (e.g., does not make purchasing decisions)